Tadataka Yamada Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Tadataka Yamada.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Tadataka Yamada. Tadataka Yamada is a Director in AGILENT TECHNOLOGIES INC ($A) and a Director in Covidien plc ($COV) and a Director in Prometheus Biosciences, Inc. ($RXDX) and a Director in Passage BIO, Inc. ($PASG) and a Director in Phathom Pharmaceuticals, Inc. ($PHAT).
Address: C/O COVIDIEN LTD. 15 HAMPSHIRE STREET MANSFIELD 02048 MA
Companies in which Tadataka Yamada is an Insider
AGILENT TECHNOLOGIES, INC.
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Tadataka Yamada: Director
Holdings: 58,374 shares
Current Value: $2,897,685
Latest Transaction: Aug 05 2020
$A Market Capitalization: $16.06B
$A Previous Close: $49.64
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Covidien plc
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Tadataka Yamada: Director
Holdings: 2,098 shares
Latest Transaction: Nov 13 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Passage BIO, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Tadataka Yamada: Director
Holdings: 0 shares
Latest Transaction: Mar 02 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Phathom Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Tadataka Yamada: Director
Holdings: 0 shares
Latest Transaction: May 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Prometheus Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Tadataka Yamada: Director
Holdings: 13,333 shares
Latest Transaction: Mar 16 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Tadataka Yamada
Sentiment: All, A, COV, PASG, PHAT, RXDX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2021 | RXDX | Prometheus Bioscie ... | Yamada Tadataka | Director | Option Exercise | C | 0.00 | 133,334 | 0 | 0 | |
| Mar 16 2021 | RXDX | Prometheus Bioscie ... | Yamada Tadataka | Director | Buy | C | 0.00 | 13,333 | 0 | 13,333 | 0 to 13.3 K |
| Aug 05 2020 | A | AGILENT TECHNOLOGI ... | Yamada Tadataka | Director | Grant | A | 93.91 | 212 | 19,909 | 58,374 | 58.2 K to 58.4 K (+0.36 %) |
| May 22 2020 | PHAT | Phathom Pharmaceut ... | Yamada Tadataka | Director | Option Exercise | A | 36.85 | 10,000 | 368,500 | 10,000 | |
| Apr 21 2020 | A | AGILENT TECHNOLOGI ... | Yamada Tadataka | Director | Grant | A | 73.01 | 205 | 14,967 | 57,977 | 57.8 K to 58 K (+0.35 %) |
| Apr 21 2020 | A | AGILENT TECHNOLOGI ... | Yamada Tadataka | Director | Grant | A | 73.01 | 1,027 | 74,980 | 57,772 | 56.7 K to 57.8 K (+1.81 %) |
| Apr 21 2020 | A | AGILENT TECHNOLOGI ... | Yamada Tadataka | Director | Grant | A | 73.01 | 3,081 | 224,941 | 56,745 | 53.7 K to 56.7 K (+5.74 %) |